|
GB0024362D0
(en)
*
|
2000-10-05 |
2000-11-22 |
Glaxo Group Ltd |
Medicaments
|
|
GB0024361D0
(en)
|
2000-10-05 |
2000-11-22 |
Glaxo Group Ltd |
Medicaments
|
|
UA82048C2
(uk)
|
2000-11-10 |
2008-03-11 |
Эли Лилли Энд Компани |
Агоністи альфа-рецепторів, активованих проліфератором пероксисом
|
|
GB0031103D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
US20040072838A1
(en)
|
2000-12-20 |
2004-04-15 |
Pierette Banker |
Thiazole and oxazole derivatives as activators of human peroxisome proliferator activated receptors
|
|
GB0031107D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
GB0031109D0
(en)
*
|
2000-12-20 |
2001-01-31 |
Glaxo Group Ltd |
Chemical compounds
|
|
US6982251B2
(en)
|
2000-12-20 |
2006-01-03 |
Schering Corporation |
Substituted 2-azetidinones useful as hypocholesterolemic agents
|
|
US7105551B2
(en)
*
|
2000-12-20 |
2006-09-12 |
Smithkline Beecham Corporation |
Thiazole derivatives for treating PPAR related disorders
|
|
US7091225B2
(en)
*
|
2000-12-20 |
2006-08-15 |
Smithkline Beecham Corporation |
Substituted oxazoles and thiazoles as hPPAR alpha agonists
|
|
US7071181B2
(en)
|
2001-01-26 |
2006-07-04 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of diabetes using sterol absorption inhibitors
|
|
AR035533A1
(es)
|
2001-01-26 |
2004-06-02 |
Schering Corp |
Uso de por lo menos un inhibidor de la absorcion de los esteroles o sus sales, solvatos, prodrogas farmaceuticamente aceptables o mezclas de los mismos para la preparacion de un medicamento para el tratamiento de la sitosterolemia, composiciones farmaceuticas, el uso de dichas composiciones para la
|
|
EP1911462A3
(en)
|
2001-01-26 |
2011-11-30 |
Schering Corporation |
Compositions comprising a sterol absorption inhibitor
|
|
IL156445A0
(en)
|
2001-01-26 |
2004-01-04 |
Schering Corp |
Combinations of peroxisome proliferator-activated receptor (ppar) activator(s) and sterol absorption inhibitor(s) and treatments for vascular indications
|
|
EP1357914A2
(en)
*
|
2001-02-02 |
2003-11-05 |
SmithKline Beecham Corporation |
Treatment of ppar mediated diseases
|
|
JP4157381B2
(ja)
*
|
2001-03-23 |
2008-10-01 |
日本ケミファ株式会社 |
ペルオキシソーム増殖剤応答性受容体の活性化剤
|
|
US20030077298A1
(en)
*
|
2001-04-13 |
2003-04-24 |
The Regents Of The University Of California, A California Corporation |
Activators and ligands of PPAR-beta/delta for the treatment of skin conditions
|
|
AU2002342244B2
(en)
*
|
2001-05-15 |
2005-06-16 |
F. Hoffmann-La Roche Ag |
Carboxylic acid substituted oxazole derivatives for use as PPAR-alpha and -gamma activators in the treatment of diabetes
|
|
GB0113231D0
(en)
*
|
2001-05-31 |
2001-07-25 |
Glaxo Group Ltd |
Chemical compounds
|
|
US7396642B2
(en)
|
2001-07-17 |
2008-07-08 |
Teijin Limited |
Methods of screening for a compound that enhances thermogenesis
|
|
US6869967B2
(en)
|
2001-07-30 |
2005-03-22 |
Novo Nordisk A/S |
Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives
|
|
US7067530B2
(en)
|
2001-07-30 |
2006-06-27 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
AU2002323776B2
(en)
*
|
2001-08-10 |
2008-07-31 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator-responsive receptor Delta
|
|
EP1435946B8
(en)
|
2001-09-14 |
2013-12-18 |
Amgen Inc. |
Linked biaryl compounds
|
|
US7056906B2
(en)
|
2001-09-21 |
2006-06-06 |
Schering Corporation |
Combinations of hormone replacement therapy composition(s) and sterol absorption inhibitor(s) and treatments for vascular conditions in post-menopausal women
|
|
MXPA04002573A
(es)
|
2001-09-21 |
2004-06-18 |
Schering Corp |
Tratamiento de xantoma con derivados de azetidinona como inhibidores de la absorcion de esterol.
|
|
US7053080B2
(en)
|
2001-09-21 |
2006-05-30 |
Schering Corporation |
Methods and therapeutic combinations for the treatment of obesity using sterol absorption inhibitors
|
|
US7220877B2
(en)
|
2001-10-17 |
2007-05-22 |
Novo Nordisk A/S |
Compounds, their preparation and use
|
|
ES2316736T3
(es)
|
2002-02-25 |
2009-04-16 |
Eli Lilly And Company |
Moduladores de receptores activados por proliferador de peroxisoma.
|
|
ES2290439T3
(es)
|
2002-02-25 |
2008-02-16 |
Eli Lilly And Company |
Moduladores del receptor activado del proliferador de peroxisomas.
|
|
US20050159598A1
(en)
*
|
2002-02-28 |
2005-07-21 |
Kenneth Ingold |
Process for preparation of chemical compounds
|
|
US7319104B2
(en)
|
2002-03-01 |
2008-01-15 |
Smithkline Beecham Corporation |
hPPARs activators
|
|
US6833380B2
(en)
*
|
2002-03-07 |
2004-12-21 |
Warner-Lambert Company, Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6867224B2
(en)
|
2002-03-07 |
2005-03-15 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods of preparation
|
|
US20030207924A1
(en)
*
|
2002-03-07 |
2003-11-06 |
Xue-Min Cheng |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6716842B2
(en)
|
2002-04-05 |
2004-04-06 |
Warner-Lambert Company, Llc |
Antidiabetic agents
|
|
US6875780B2
(en)
|
2002-04-05 |
2005-04-05 |
Warner-Lambert Company |
Compounds that modulate PPAR activity and methods for their preparation
|
|
KR100474202B1
(ko)
*
|
2002-05-04 |
2005-03-08 |
강헌중 |
티아졸 유도체의 제조방법 및 이를 제조하기 위한 중간체
|
|
JP2004277397A
(ja)
*
|
2002-05-24 |
2004-10-07 |
Takeda Chem Ind Ltd |
１，２−アゾール誘導体
|
|
EP1513817A1
(en)
*
|
2002-05-24 |
2005-03-16 |
Takeda Pharmaceutical Company Limited |
1, 2-azole derivatives with hypoglycemic and hypolipidemic activity
|
|
ES2291688T3
(es)
*
|
2002-07-03 |
2008-03-01 |
F. Hoffmann-La Roche Ag |
Derivados de oxazol y su empleo como sensibilizadores a la insulina.
|
|
BR0312503A
(pt)
*
|
2002-07-09 |
2007-06-26 |
Bristol Myers Squibb Co |
derivados heterocìclicos substituìdos úteis como agentes antidiabéticos e antiobesidade, composição farmacêutica, uso e combinação dos mesmos
|
|
US7232828B2
(en)
|
2002-08-10 |
2007-06-19 |
Bethesda Pharmaceuticals, Inc. |
PPAR Ligands that do not cause fluid retention, edema or congestive heart failure
|
|
ES2350340T3
(es)
*
|
2002-08-30 |
2011-01-21 |
F. Hoffmann-La Roche Ag |
Nuevos compuestos de 2-aril-tiazol como agonistas de pparalfa y ppargamma.
|
|
CA2499380A1
(en)
|
2002-09-05 |
2004-03-18 |
Novo Nordisk A/S |
Novel vinyl carboxylic acid derivatives and their therapeutical use
|
|
US7368578B2
(en)
|
2002-09-10 |
2008-05-06 |
Takeda Pharmaceutical Company Limited |
Five-membered heterocyclic compounds
|
|
JP2004123732A
(ja)
*
|
2002-09-10 |
2004-04-22 |
Takeda Chem Ind Ltd |
５員複素環化合物
|
|
NZ537979A
(en)
|
2002-09-12 |
2007-08-31 |
Hoffmann La Roche |
N-substituted-1H-indol-5-propionic acid compounds as PPAR agonists useful for the treatment of diabetes
|
|
US7162262B2
(en)
|
2002-09-23 |
2007-01-09 |
Telefonaktiebolaget Lm Ericsson (Publ) |
Methods, systems and computer program products for requesting received power levels based on received block error rates utilizing an anti-windup and/or emergency procedure
|
|
JP4584714B2
(ja)
|
2002-10-28 |
2010-11-24 |
ハイ・ポイント・ファーマスーティカルズ、エルエルシー |
新規化合物、その調製および使用
|
|
AU2003273783C1
(en)
|
2002-10-28 |
2010-08-12 |
Vtv Therapeutics Llc |
Novel compounds and their use as PPAR-modulators
|
|
US20050080115A1
(en)
|
2002-10-28 |
2005-04-14 |
Lone Jeppesen |
Novel compounds, their preparation and use
|
|
US7129268B2
(en)
|
2002-10-28 |
2006-10-31 |
Novo Nordisk A/S |
Peroxisome proliferator activated receptor-active arylene acetic acid derivatives
|
|
WO2004043457A1
(en)
|
2002-11-06 |
2004-05-27 |
Schering Corporation |
Cholesterol absorptions inhibitors for the treatment of autoimmune disorders
|
|
AU2003277576A1
(en)
*
|
2002-11-08 |
2004-06-07 |
Takeda Pharmaceutical Company Limited |
Receptor function controlling agent
|
|
ATE405560T1
(de)
|
2002-11-25 |
2008-09-15 |
Hoffmann La Roche |
Indolderivaten
|
|
US7816385B2
(en)
|
2002-12-20 |
2010-10-19 |
High Point Pharmaceuticals, Llc |
Dimeric dicarboxylic acid derivatives, their preparation and use
|
|
JP2006516254A
(ja)
|
2003-01-06 |
2006-06-29 |
イーライ・リリー・アンド・カンパニー |
Ｐｐａｒモジュレータとしての縮合ヘテロ環誘導体
|
|
DE10308354A1
(de)
*
|
2003-02-27 |
2004-12-23 |
Aventis Pharma Deutschland Gmbh |
Cycloalkylderivate mit biosteren Carbonsäure-Gruppen, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
|
|
US7148246B2
(en)
*
|
2003-02-27 |
2006-12-12 |
Sanofi-Aventis Deutschland Gmbh |
Cycloalkyl derivatives having bioisosteric carboxylic acid groups, processes for their preparation and their use as pharmaceuticals
|
|
CA2517572C
(en)
|
2003-03-07 |
2011-12-13 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
|
EP1601668B1
(en)
|
2003-03-07 |
2008-08-27 |
Schering Corporation |
Substituted azetidinone compounds, formulations and uses thereof for the treatment of hypercholesterolemia
|
|
JP2006519869A
(ja)
|
2003-03-07 |
2006-08-31 |
シェーリング コーポレイション |
置換アゼチジノン化合物、置換アゼチジノン化合物を調製するためのプロセス、それらの処方物および使用
|
|
US7459442B2
(en)
|
2003-03-07 |
2008-12-02 |
Schering Corporation |
Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
|
|
US7244763B2
(en)
|
2003-04-17 |
2007-07-17 |
Warner Lambert Company Llc |
Compounds that modulate PPAR activity and methods of preparation
|
|
US6987118B2
(en)
*
|
2003-05-21 |
2006-01-17 |
Pfizer Inc. |
Tetrahydroisoquinoline derivatives as PPAR-alpha activators
|
|
JP5016922B2
(ja)
|
2003-09-19 |
2012-09-05 |
ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ |
４−（（フェノキシアルキル）チオ）−フェノキシ酢酸および類似化合物
|
|
EP1667964B1
(en)
|
2003-09-19 |
2009-07-22 |
Janssen Pharmaceutica N.V. |
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
|
|
ES2390053T3
(es)
|
2003-09-22 |
2012-11-06 |
Ono Pharmaceutical Co., Ltd. |
Derivado de ácido fenilacético, procedimiento para producir el mismo y uso
|
|
CA2547430A1
(en)
|
2003-11-26 |
2005-06-09 |
Takeda Pharmaceutical Company Limited |
Receptor function regulating agent
|
|
WO2005060958A1
(en)
*
|
2003-12-19 |
2005-07-07 |
Kalypsys, Inc. |
(5- (2-phenyl)-thiazol-5-ylmethoxy)-indol-1-yl) -acetic acid derivatives and related compounds as modulators of the human ppar-delta receptor for the treatment of metabolic disorders such as type 2 diabetes
|
|
AU2004309271A1
(en)
|
2003-12-25 |
2005-07-14 |
Takeda Pharmaceutical Company Limited |
3-(4-benzyloxyphenyl)propanoic acid derivatives
|
|
EP1698624B1
(en)
|
2003-12-26 |
2012-06-27 |
Takeda Pharmaceutical Company Limited |
Phenylpropanoic acid derivatives
|
|
JP5299810B2
(ja)
*
|
2004-02-27 |
2013-09-25 |
アムジエン・インコーポレーテツド |
代謝疾患の治療に使用するための、化合物、薬学的組成物及び方法
|
|
WO2005097098A2
(en)
*
|
2004-04-01 |
2005-10-20 |
Aventis Pharmaceuticals Inc. |
Use of ppr delta agonists for treating demyelinating diseases
|
|
AU2005230838A1
(en)
*
|
2004-04-01 |
2005-10-20 |
Aventis Pharmaceuticals Inc. |
1,3,4-oxadiazol-2-ones as PPAR delta
|
|
EP1586573B1
(en)
|
2004-04-01 |
2007-02-07 |
Sanofi-Aventis Deutschland GmbH |
Oxadiazolones, processes for their preparation and their use as pharmaceuticals
|
|
NZ550857A
(en)
*
|
2004-04-01 |
2009-12-24 |
Aventis Pharma Inc |
1,3,4-oxadiazol-2-ones as PPAR delta modulators
|
|
US8053598B2
(en)
|
2004-05-05 |
2011-11-08 |
High Point Pharmaceuticals, Llc |
Compounds, their preparation and use
|
|
DE602005024384D1
(de)
|
2004-05-05 |
2010-12-09 |
High Point Pharmaceuticals Llc |
Neue verbindungen, ihre herstellung und verwendung
|
|
PE20060315A1
(es)
*
|
2004-05-24 |
2006-05-15 |
Irm Llc |
Compuestos de tiazol como moduladores de ppar
|
|
AU2005247473A1
(en)
*
|
2004-05-25 |
2005-12-08 |
Metabolex, Inc. |
Substituted triazoles as modulators of PPAR and methods of their preparation
|
|
US20060014785A1
(en)
*
|
2004-05-25 |
2006-01-19 |
Metabolex, Inc. |
Bicyclic, substituted triazoles as modulators of ppar and methods of their preparation
|
|
JP2007269630A
(ja)
*
|
2004-06-23 |
2007-10-18 |
Toudai Tlo Ltd |
インスリン分泌促進剤
|
|
MY147518A
(en)
|
2004-09-15 |
2012-12-31 |
Janssen Pharmaceutica Nv |
4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
|
|
EP1812386A4
(en)
*
|
2004-10-22 |
2010-01-06 |
Seoul Nat Univ Ind Foundation |
PROCESS FOR ALKYLARYLSULPIDE DERIVATIVES AND NEW SULFIDE COMPOUNDS
|
|
WO2006056845A1
(en)
*
|
2004-11-23 |
2006-06-01 |
Warner-Lambert Company Llc |
7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoic acid derivatives as hmg co-a reductase inhibitors for the treatment of lipidemia
|
|
US20080051418A1
(en)
*
|
2004-11-26 |
2008-02-28 |
Tsuyoshi Maekawa |
Arylalkanoic Acid Derivative
|
|
CN101146783B
(zh)
*
|
2004-12-31 |
2011-02-02 |
财团法人首尔大学校产学协力财团 |
含有有机硒的化合物及其应用
|
|
WO2006071103A1
(en)
*
|
2004-12-31 |
2006-07-06 |
Heonjoong Kang |
Organoselenium containing compounds and their use
|
|
FR2880886B1
(fr)
*
|
2005-01-14 |
2007-04-06 |
Merck Sante Soc Par Actions Si |
Derives de l'acide 6-phenylhex-5-enoique, procedes pour leur preparation, compositions pharmaceutiques les contenant et applications en therapeutique
|
|
CN101146784B
(zh)
*
|
2005-02-25 |
2012-09-05 |
财团法人首尔大学校产学协力财团 |
作为PPARδ配体的噻唑衍生物及其制造方法
|
|
JP4869338B2
(ja)
*
|
2005-05-07 |
2012-02-08 |
ソウル ナショナル ユニバーシティー インダストリー ファンデーション |
ペルオキシソーム増殖因子活性化受容体δリガンドの製造方法及びこれを製造するための中間体
|
|
US7465804B2
(en)
*
|
2005-05-20 |
2008-12-16 |
Amgen Inc. |
Compounds, pharmaceutical compositions and methods for their use in treating metabolic disorders
|
|
WO2006126541A1
(ja)
*
|
2005-05-27 |
2006-11-30 |
Shionogi & Co., Ltd. |
ビタミンｋ類含有医薬組成物
|
|
JPWO2006126514A1
(ja)
|
2005-05-27 |
2008-12-25 |
塩野義製薬株式会社 |
イソキサゾール骨格を有するアリール酢酸誘導体
|
|
ES2372617T3
(es)
|
2005-06-30 |
2012-01-24 |
High Point Pharmaceuticals, Llc |
Ácidos fenoxiacéticos como activadores de ppar-delta.
|
|
WO2007033002A1
(en)
|
2005-09-14 |
2007-03-22 |
Amgen Inc. |
Conformationally constrained 3- (4-hydroxy-phenyl) - substituted-propanoic acids useful for treating metabolic disorders
|
|
JO3006B1
(ar)
|
2005-09-14 |
2016-09-05 |
Janssen Pharmaceutica Nv |
املاح ليسين مبتكرة من مشتقات حامض 4-((فينوكسي الكيل)ثيو) فينوكسي الخليك
|
|
JP2009509988A
(ja)
*
|
2005-09-29 |
2009-03-12 |
サノフィ−アベンティス |
フェニル−及びピリジニル−１，２，４−オキサジアゾロン誘導体、その製造方法、及び医薬品としてのその使用
|
|
AU2006299092A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Sanofi-Aventis |
Phenyl-(1,2,4)-oxadiazol-5-one derivatives with phenyl group, processes for their preparation and their use as pharmaceuticals
|
|
CN103224477A
(zh)
|
2005-12-22 |
2013-07-31 |
高点制药有限责任公司 |
作为PPAR-δ活化剂的苯氧基乙酸
|
|
EP2044042A2
(en)
*
|
2006-01-10 |
2009-04-08 |
SmithKline Beecham Corporation |
Polymorphic forms of { 2-methyl-4- [4-methyl-2- (trifluoromethylphenyl) thiazol-5-methylthiol phenoxy}-acetic acid
|
|
CN101007790B
(zh)
*
|
2006-01-27 |
2011-03-30 |
北京摩力克科技有限公司 |
草氨酸衍生物、其制备方法和医药用途
|
|
CA2640476A1
(en)
*
|
2006-02-03 |
2007-08-16 |
Eli Lilly And Company |
Compounds and methods for modulating fx-receptors
|
|
JP2009132620A
(ja)
*
|
2006-03-07 |
2009-06-18 |
Astellas Pharma Inc |
フェニルチアゾール誘導体
|
|
US7943612B2
(en)
|
2006-03-09 |
2011-05-17 |
High Point Pharmaceuticals, Llc |
Compounds that modulate PPAR activity, their preparation and use
|
|
CA2646430A1
(en)
*
|
2006-03-14 |
2007-09-20 |
Amgen Inc. |
Bicyclic carboxylic acid derivatives useful for treating metabolic disorders
|
|
CN101466687B
(zh)
*
|
2006-04-18 |
2012-04-11 |
日本化学医药株式会社 |
过氧化物酶体增殖剂激活受体δ的激活剂
|
|
UY30288A1
(es)
|
2006-04-18 |
2007-08-31 |
Janssen Pharmaceutica Nv |
Derivados del ácido benzoazepin-oxi-acético como agonistas de ppar-delta usados para aumentar hdl-c. reducir ldl-c y reducir colesterol
|
|
US20100197950A1
(en)
*
|
2006-06-08 |
2010-08-05 |
Kaare Gyberg Rasmussen |
Process for preparing phenoxy acetic acid derivatives
|
|
US20080004281A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Kalypsys, Inc. |
Methods for the modulation of crp by the selective modulation of ppar delta
|
|
WO2008016175A1
(en)
*
|
2006-08-03 |
2008-02-07 |
Nippon Chemiphar Co., Ltd. |
Activator for peroxisome proliferator activated receptor
|
|
AU2007292816B2
(en)
*
|
2006-09-07 |
2011-11-17 |
Amgen Inc. |
Benzo-fused compounds for use in treating metabolic disorders
|
|
CA2662305C
(en)
*
|
2006-09-07 |
2012-04-17 |
Amgen Inc. |
Heterocyclic gpr40 modulators
|
|
US9308198B2
(en)
|
2006-09-08 |
2016-04-12 |
Rhode Island Hospital |
Treatment, prevention, and reversal of alcohol-induced brain disease
|
|
ES2399147T3
(es)
*
|
2006-09-08 |
2013-03-26 |
Rhode Island Hospital |
Tratamiento, prevención y reversión de una enfermedad hepática alcohólica
|
|
US8519145B2
(en)
|
2006-12-02 |
2013-08-27 |
Seoul National University Industry Foundation |
Aryl compounds as PPAR ligands and their use
|
|
CA2672420A1
(en)
|
2006-12-29 |
2008-07-10 |
The Salk Institute For Biological Studies |
Methods for enhancing exercise performance
|
|
RU2444518C2
(ru)
*
|
2007-01-08 |
2012-03-10 |
Сеул Нэшнл Юниверсити Индастри Фаундейшн |
ПРОИЗВОДНОЕ ТИАЗОЛА КАК PPARδ ЛИГАНД И ФАРМАЦЕВТИЧЕСКИЙ, КОСМЕТИЧЕСКИЙ И ДИЕТИЧЕСКИЙ ПИЩЕВОЙ ПРОДУКТ, СОДЕРЖАЩИЙ ЕГО
|
|
JP5175866B2
(ja)
*
|
2007-02-22 |
2013-04-03 |
アイアールエム・リミテッド・ライアビリティ・カンパニー |
Ｇタンパク質共役受容体を調節するための化合物および方法
|
|
EP2139843B1
(en)
*
|
2007-04-16 |
2013-12-25 |
Amgen, Inc |
Substituted biphenyl phenoxy-, thiophenyl- and aminophenylpropanoic acid gpr40 modulators
|
|
WO2008154023A1
(en)
*
|
2007-06-11 |
2008-12-18 |
Cerenis Therapeutics S.A. |
Novel uses of ppar delta agonists
|
|
GB0712653D0
(en)
|
2007-06-28 |
2007-08-08 |
Syngenta Ltd |
Novel herbicides
|
|
GB0717082D0
(en)
|
2007-09-03 |
2007-10-10 |
Syngenta Ltd |
Novel herbicides
|
|
CN102083783A
(zh)
|
2007-10-10 |
2011-06-01 |
安姆根有限公司 |
取代的联苯gpr40调节剂
|
|
US20090163481A1
(en)
*
|
2007-12-13 |
2009-06-25 |
Murphy Brian J |
Ppar-delta ligands and methods of their use
|
|
WO2009111056A1
(en)
|
2008-03-06 |
2009-09-11 |
Amgen Inc. |
Conformationally constrained carboxylic acid derivatives useful for treating metabolic disorders
|
|
MX2010011252A
(es)
|
2008-04-15 |
2010-11-30 |
Nippon Chemiphar Co |
Activador para el receptor activado por el proliferador de peroxisoma.
|
|
CN101643451B
(zh)
|
2008-08-07 |
2013-03-06 |
浙江海正药业股份有限公司 |
过氧化物酶增殖物激活受体亚型δ类激动剂化合物及其制备方法
|
|
AU2009303475B2
(en)
|
2008-10-15 |
2012-09-13 |
Amgen Inc. |
Spirocyclic GPR40 modulators
|
|
JP5694941B2
(ja)
|
2008-10-17 |
2015-04-01 |
シーマベイ セラピューティクス，インコーポレイティド |
小型高密度ｌｄｌ粒子を減少させる方法
|
|
EP2540711A4
(en)
*
|
2010-02-25 |
2014-01-22 |
Snu R&Db Foundation |
Selenium-Zolderivate with ligand for the activation of the peroxisome-proliferator-activated receptor (PPAR), preparation method therefor and use of the chemical compounds
|
|
CN102285933B
(zh)
*
|
2010-06-18 |
2016-03-09 |
浙江海正药业股份有限公司 |
一种对亚型过氧化物酶增殖物激活受体具有激动作用的化合物、其制备方法和应用
|
|
US20130156720A1
(en)
|
2010-08-27 |
2013-06-20 |
Ironwood Pharmaceuticals, Inc. |
Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders
|
|
RU2013114390A
(ru)
*
|
2010-08-31 |
2014-10-10 |
СНУ Ар энд ДиБи ФАУНДЕЙШН |
Применение фетального репрограммирования посредством ppar-дельта-агониста
|
|
US10181018B2
(en)
*
|
2013-03-14 |
2019-01-15 |
The University Of Toledo |
Analogs of proxisome proliferator activated receptor (PPAR) agonists and methods of using the same
|
|
US9695137B2
(en)
*
|
2013-03-14 |
2017-07-04 |
The University Of Toledo |
Analogs of peroxisome proliferator activated receptor (PPAR) agonists, and methods of using the same
|
|
EP3756661A1
(en)
|
2013-09-09 |
2020-12-30 |
vTv Therapeutics LLC |
Use of a ppar-delta agonist for treating muscle atrophy
|
|
JP7397491B2
(ja)
|
2018-10-23 |
2023-12-13 |
国立研究開発法人科学技術振興機構 |
ＰＰＡＲδ活性化剤
|
|
US11634387B2
(en)
|
2019-09-26 |
2023-04-25 |
Abionyx Pharma Sa |
Compounds useful for treating liver diseases
|
|
WO2022189856A1
(en)
*
|
2021-03-08 |
2022-09-15 |
Abionyx Pharma Sa |
Compounds useful for treating liver diseases
|
|
WO2023147309A1
(en)
|
2022-01-25 |
2023-08-03 |
Reneo Pharmaceuticals, Inc. |
Use of ppar-delta agonists in the treatment of disease
|